Indian Medical Association opposes decision to allow homeopaths to prescribe modern medicines post pharma course

The Indian Medical Association (IMA) on Monday criticised the notification by Maharashtra Medical Council (MMC) that will allow homeopaths to prescribe modern medicines after completing a six-month course in pharmacology.

This came on the back of Maharashtra Medical Council (MMC) notification of June 30, which mentioned that the state Medical Education and Drugs department has given permission to start a Certificate Course in Modern Pharmacology (CCMP) for homeopathy practitioners to practice in modern medicine.

“This is absolutely wrong and we are against it as it will ‘hoodwink’ patients and dilute modern medical practices. Currently, the matter is subjudice, with a petition filed by IMA before Bombay High Court, which has issued a stay on this,” Indian Medical Association (IMA) national vice president Shivkumar Utture told PTI.

In 2014, the state government amended Maharashtra Homoeopathic Practitioners Act and Maharashtra Medical Council Act 1965 and allowed homeopaths to prescribe modern medicines under certain conditions, he said.

The IMA challenged the amendments in the Bombay High Court, he added.

However, after this notification, he said, “we have to approach the court and ask it to expedite the matter”.

“The notification undermines the statutory and ethical framework of MMC and will lead to confusion among patients,” he added.

MMC decided to implement the 2014 amendment in a meeting in February this year.

As per the notification, Maharashtra Medical Association (MMA) directed all CCMP qualified doctors to register, for which a portal will be launched on MMA website with specific instruction from July 15.

Related Posts

Odisha Receives Investment Commitments Worth ₹7,043 Cr in Pharma & Medtech

Odisha has received investment commitments worth ₹7,043 crore across the pharmaceutical and medical technology sectors, marking a major step in strengthening the state’s position as an emerging healthcare manufacturing hub.…

Cough Syrup Racket Busted: Kingpin Shubham Jaiswal skips ED summons; Here’s what happens next

Mastermind of India’s massive codeine cough syrup racket skips ED summons- what’s next for Shubham Jaiswal? With arrest warrants, Red Corner Notices, and cross-border drug links, the investigation could expose…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Odisha Receives Investment Commitments Worth ₹7,043 Cr in Pharma & Medtech

Odisha Receives Investment Commitments Worth ₹7,043 Cr in Pharma & Medtech

Cough Syrup Racket Busted: Kingpin Shubham Jaiswal skips ED summons; Here’s what happens next

Cough Syrup Racket Busted: Kingpin Shubham Jaiswal skips ED summons; Here’s what happens next

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Aytu BioPharma launches depression drug EXXUA in U.S. market

Aytu BioPharma launches depression drug EXXUA in U.S. market

Delhi govt carries out 27 raids against fake medicine

Delhi govt carries out 27 raids against fake medicine

Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16

Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16